Florida’s importation program hasn’t brought in a single Canadian drug. It’s not cost-effective and it could be dangerous.

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

Cancer Antibody Drug Conjugates Treatment Market USD 50 Billion Opportunity Says Kuick Research. Delhi, July 11, 2025 (GLOBE ...

Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

US supplement maker Robinson Pharma has unveiled new global distribution partnerships to safeguard brand quality and consumer ...

Men around the world dealing with sexual impotence have been treated for years with the drug sildenafil, sold under brand ...

KalVista Pharma has finally received FDA approval for its oral kallikrein inhibitor sebetralstat, becoming the first ...

Wordplay flirting with substance abuse in prime time and political barbs have brought drugs into the media. Do they normalize ...

ABOUT two weeks ago, the Trinidad and Tobago Pharmacy Board rejected the Chamber of Industry and Commerce’s request for a 90-day “grace period” to explore other options following a cease-and-desist ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.